questionsmedicales.fr
Virus
Virus à ADN
Adenoviridae
Mastadenovirus
Mastadenovirus : Questions médicales fréquentes
Termes MeSH sélectionnés :
Administration, Inhalation
Diagnostic
5
Infections virales
Adenovirus
Diagnostic médical
Tests de laboratoire
Adenovirus
Culture virale
Anticorps
Adenovirus
Sérologie
Symptômes
Infections virales
Adenovirus
Tests rapides
Adenovirus
Sensibilité
Symptômes
5
Symptômes
Infections virales
Adenovirus
Diarrhée
Adenovirus
Symptômes gastro-intestinaux
Contagiosité
Transmission
Adenovirus
Gravité
Infections virales
Adenovirus
Symptômes persistants
Fatigue
Adenovirus
Prévention
5
Prévention
Hygiène
Adenovirus
Vaccins
Adenovirus
Prévention
Transmission
Prévention
Adenovirus
Masques
Prévention
Adenovirus
Désinfection
Prévention
Adenovirus
Traitements
5
Traitement
Infections virales
Adenovirus
Antiviraux
Adenovirus
Traitement
Symptômes
Analgésiques
Adenovirus
Antibiotiques
Infections virales
Adenovirus
Consultation médicale
Complications
Adenovirus
Complications
5
Complications
Pneumonie
Adenovirus
Conjonctivite
Complications
Adenovirus
Immunodépression
Complications
Adenovirus
Mortalité
Complications
Adenovirus
Surveillance
Complications
Adenovirus
Facteurs de risque
5
Facteurs de risque
Immunodépression
Adenovirus
Saisonnalité
Infections virales
Adenovirus
Conditions de vie
Transmission
Adenovirus
Antécédents médicaux
Infections respiratoires
Adenovirus
Stress
Immunité
Adenovirus
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Mastadenovirus : Questions médicales les plus fréquentes",
"headline": "Mastadenovirus : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Mastadenovirus : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-05",
"dateModified": "2025-03-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Mastadenovirus"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Adenoviridae",
"url": "https://questionsmedicales.fr/mesh/D000256",
"about": {
"@type": "MedicalCondition",
"name": "Adenoviridae",
"code": {
"@type": "MedicalCode",
"code": "D000256",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.280.030"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Adénovirus humains",
"alternateName": "Adenoviruses, Human",
"url": "https://questionsmedicales.fr/mesh/D000260",
"about": {
"@type": "MedicalCondition",
"name": "Adénovirus humains",
"code": {
"@type": "MedicalCode",
"code": "D000260",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.280.030.500.350"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Adénovirus porcins",
"alternateName": "Adenoviruses, Porcine",
"url": "https://questionsmedicales.fr/mesh/D025662",
"about": {
"@type": "MedicalCondition",
"name": "Adénovirus porcins",
"code": {
"@type": "MedicalCode",
"code": "D025662",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.280.030.500.675"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Adénovirus simiens",
"alternateName": "Adenoviruses, Simian",
"url": "https://questionsmedicales.fr/mesh/D000261",
"about": {
"@type": "MedicalCondition",
"name": "Adénovirus simiens",
"code": {
"@type": "MedicalCode",
"code": "D000261",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.280.030.500.700"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Mastadenovirus",
"alternateName": "Mastadenovirus",
"code": {
"@type": "MedicalCode",
"code": "D017921",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Meriane Demoliner",
"url": "https://questionsmedicales.fr/author/Meriane%20Demoliner",
"affiliation": {
"@type": "Organization",
"name": "Laboratório de Microbiologia Molecular, Universidade Feevale, ERS 239 no. 2755, Novo Hamburgo, RS, 93352-000, Brazil."
}
},
{
"@type": "Person",
"name": "Fernando Rosado Spilki",
"url": "https://questionsmedicales.fr/author/Fernando%20Rosado%20Spilki",
"affiliation": {
"@type": "Organization",
"name": "Laboratório de Microbiologia Molecular, Universidade Feevale, ERS 239 no. 2755, Novo Hamburgo, RS, 93352-000, Brazil."
}
},
{
"@type": "Person",
"name": "Juliana Schons Gularte",
"url": "https://questionsmedicales.fr/author/Juliana%20Schons%20Gularte",
"affiliation": {
"@type": "Organization",
"name": "Laboratório de Microbiologia Molecular, Universidade Feevale, ERS 239 no. 2755, Novo Hamburgo, RS, 93352-000, Brazil."
}
},
{
"@type": "Person",
"name": "Viviane Girardi",
"url": "https://questionsmedicales.fr/author/Viviane%20Girardi",
"affiliation": {
"@type": "Organization",
"name": "Laboratório de Microbiologia Molecular, Universidade Feevale, ERS 239 no. 2755, Novo Hamburgo, RS, 93352-000, Brazil. 0178103@feevale.br."
}
},
{
"@type": "Person",
"name": "Larissa Mallmann",
"url": "https://questionsmedicales.fr/author/Larissa%20Mallmann",
"affiliation": {
"@type": "Organization",
"name": "Universidade Feevale, Instituto de Ciências da Saúde, Laboratório de Microbiologia Molecular, Novo Hamburgo, Rio Grande do Sul, Brazil."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Inhalable polymeric microparticles as pharmaceutical porous powder for drug administration.",
"datePublished": "2022-10-26",
"url": "https://questionsmedicales.fr/article/36309290",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijpharm.2022.122325"
}
},
{
"@type": "ScholarlyArticle",
"name": "Liposomal form of erlotinib for local inhalation administration and efficiency of its transport to the lungs.",
"datePublished": "2023-02-07",
"url": "https://questionsmedicales.fr/article/36758881",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijpharm.2023.122695"
}
},
{
"@type": "ScholarlyArticle",
"name": "Scientific and regulatory activities initiated by the U.S. Food and drug administration to foster approvals of generic dry powder inhalers: Bioequivalence perspective.",
"datePublished": "2022-09-05",
"url": "https://questionsmedicales.fr/article/36067967",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.addr.2022.114526"
}
},
{
"@type": "ScholarlyArticle",
"name": "Scientific and regulatory activities initiated by the U.S. food and drug administration to foster approvals of generic dry powder inhalers: Quality perspective.",
"datePublished": "2022-08-28",
"url": "https://questionsmedicales.fr/article/36038083",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.addr.2022.114519"
}
},
{
"@type": "ScholarlyArticle",
"name": "The match between adhesive mixture powder formulations for inhalation and the inhaler device.",
"datePublished": "2023-04-26",
"url": "https://questionsmedicales.fr/article/37116546",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejps.2023.106457"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Virus",
"item": "https://questionsmedicales.fr/mesh/D014780"
},
{
"@type": "ListItem",
"position": 3,
"name": "Virus à ADN",
"item": "https://questionsmedicales.fr/mesh/D004267"
},
{
"@type": "ListItem",
"position": 4,
"name": "Adenoviridae",
"item": "https://questionsmedicales.fr/mesh/D000256"
},
{
"@type": "ListItem",
"position": 5,
"name": "Mastadenovirus",
"item": "https://questionsmedicales.fr/mesh/D017921"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Mastadenovirus - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Mastadenovirus",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Mastadenovirus",
"description": "Comment diagnostique-t-on une infection par Mastadenovirus ?\nQuels tests sont utilisés pour identifier le Mastadenovirus ?\nLes anticorps peuvent-ils détecter le Mastadenovirus ?\nQuels symptômes orientent vers une infection par Mastadenovirus ?\nPeut-on utiliser des tests rapides pour le Mastadenovirus ?",
"url": "https://questionsmedicales.fr/mesh/D017921?mesh_terms=Administration,+Inhalation#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Mastadenovirus",
"description": "Quels sont les symptômes courants du Mastadenovirus ?\nLe Mastadenovirus cause-t-il des symptômes gastro-intestinaux ?\nLes infections par Mastadenovirus sont-elles contagieuses ?\nLes symptômes du Mastadenovirus sont-ils graves ?\nPeut-on avoir des symptômes prolongés après une infection ?",
"url": "https://questionsmedicales.fr/mesh/D017921?mesh_terms=Administration,+Inhalation#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Mastadenovirus",
"description": "Comment prévenir les infections par Mastadenovirus ?\nLes vaccins existent-ils contre le Mastadenovirus ?\nFaut-il éviter les lieux bondés pour prévenir l'infection ?\nLe port de masque aide-t-il à prévenir le Mastadenovirus ?\nLes surfaces doivent-elles être désinfectées pour prévenir l'infection ?",
"url": "https://questionsmedicales.fr/mesh/D017921?mesh_terms=Administration,+Inhalation#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Mastadenovirus",
"description": "Quel est le traitement principal pour une infection par Mastadenovirus ?\nDes antiviraux sont-ils efficaces contre le Mastadenovirus ?\nComment soulager les symptômes du Mastadenovirus ?\nLes antibiotiques sont-ils utiles contre le Mastadenovirus ?\nQuand consulter un médecin pour une infection par Mastadenovirus ?",
"url": "https://questionsmedicales.fr/mesh/D017921?mesh_terms=Administration,+Inhalation#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Mastadenovirus",
"description": "Quelles sont les complications possibles d'une infection par Mastadenovirus ?\nLe Mastadenovirus peut-il causer des infections oculaires ?\nLes personnes immunodéprimées risquent-elles plus de complications ?\nLes infections par Mastadenovirus peuvent-elles être mortelles ?\nComment surveiller les complications d'une infection par Mastadenovirus ?",
"url": "https://questionsmedicales.fr/mesh/D017921?mesh_terms=Administration,+Inhalation#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Mastadenovirus",
"description": "Quels sont les facteurs de risque d'infection par Mastadenovirus ?\nLa saison influence-t-elle les infections par Mastadenovirus ?\nLes conditions de vie surpeuplées augmentent-elles le risque ?\nLes antécédents d'infections respiratoires augmentent-ils le risque ?\nLe stress peut-il affecter le risque d'infection par Mastadenovirus ?",
"url": "https://questionsmedicales.fr/mesh/D017921?mesh_terms=Administration,+Inhalation#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on une infection par Mastadenovirus ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par PCR sur des échantillons respiratoires ou fécaux."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour identifier le Mastadenovirus ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests PCR et les cultures virales sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les anticorps peuvent-ils détecter le Mastadenovirus ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests sérologiques peuvent détecter des anticorps spécifiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes orientent vers une infection par Mastadenovirus ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, toux, maux de gorge et diarrhée sont des symptômes fréquents."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des tests rapides pour le Mastadenovirus ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests rapides existent, mais leur sensibilité peut varier."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants du Mastadenovirus ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, toux, congestion nasale et diarrhée."
}
},
{
"@type": "Question",
"name": "Le Mastadenovirus cause-t-il des symptômes gastro-intestinaux ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut provoquer des diarrhées et des douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Les infections par Mastadenovirus sont-elles contagieuses ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles se propagent par contact direct ou gouttelettes respiratoires."
}
},
{
"@type": "Question",
"name": "Les symptômes du Mastadenovirus sont-ils graves ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont généralement bénins mais peuvent être graves chez les immunodéprimés."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes prolongés après une infection ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes persistants peuvent survenir, notamment la fatigue."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections par Mastadenovirus ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hygiène des mains et l'évitement des contacts rapprochés sont essentiels."
}
},
{
"@type": "Question",
"name": "Les vaccins existent-ils contre le Mastadenovirus ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccin approuvé pour le Mastadenovirus."
}
},
{
"@type": "Question",
"name": "Faut-il éviter les lieux bondés pour prévenir l'infection ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, éviter les foules peut réduire le risque de transmission."
}
},
{
"@type": "Question",
"name": "Le port de masque aide-t-il à prévenir le Mastadenovirus ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le port de masque peut réduire la transmission par gouttelettes."
}
},
{
"@type": "Question",
"name": "Les surfaces doivent-elles être désinfectées pour prévenir l'infection ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, désinfecter les surfaces fréquemment touchées aide à prévenir la propagation."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour une infection par Mastadenovirus ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement antiviral spécifique, le repos et l'hydratation sont recommandés."
}
},
{
"@type": "Question",
"name": "Des antiviraux sont-ils efficaces contre le Mastadenovirus ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antiviraux ne sont généralement pas efficaces contre ce virus."
}
},
{
"@type": "Question",
"name": "Comment soulager les symptômes du Mastadenovirus ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analgésiques et des antipyrétiques peuvent aider à soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils utiles contre le Mastadenovirus ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont pas efficaces contre les infections virales."
}
},
{
"@type": "Question",
"name": "Quand consulter un médecin pour une infection par Mastadenovirus ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez si les symptômes s'aggravent ou si des complications apparaissent."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles d'une infection par Mastadenovirus ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure pneumonie et bronchite, surtout chez les jeunes enfants."
}
},
{
"@type": "Question",
"name": "Le Mastadenovirus peut-il causer des infections oculaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut provoquer des conjonctivites virales dans certains cas."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées risquent-elles plus de complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont plus susceptibles de développer des complications graves."
}
},
{
"@type": "Question",
"name": "Les infections par Mastadenovirus peuvent-elles être mortelles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rarement, mais des cas graves peuvent survenir chez les patients à risque."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications d'une infection par Mastadenovirus ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surveillance clinique et des examens complémentaires sont nécessaires."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'infection par Mastadenovirus ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les jeunes enfants, les personnes âgées et les immunodéprimés sont à risque élevé."
}
},
{
"@type": "Question",
"name": "La saison influence-t-elle les infections par Mastadenovirus ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections sont plus fréquentes en hiver et au printemps."
}
},
{
"@type": "Question",
"name": "Les conditions de vie surpeuplées augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la promiscuité favorise la transmission du virus."
}
},
{
"@type": "Question",
"name": "Les antécédents d'infections respiratoires augmentent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents d'infections respiratoires peuvent prédisposer à l'infection."
}
},
{
"@type": "Question",
"name": "Le stress peut-il affecter le risque d'infection par Mastadenovirus ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affaiblir le système immunitaire et augmenter le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 02/03/2025
Contenu vérifié selon les dernières recommandations médicales
6 publications dans cette catégorie
Affiliations :
Laboratório de Microbiologia Molecular, Universidade Feevale, ERS 239 no. 2755, Novo Hamburgo, RS, 93352-000, Brazil.
5 publications dans cette catégorie
Affiliations :
Laboratório de Microbiologia Molecular, Universidade Feevale, ERS 239 no. 2755, Novo Hamburgo, RS, 93352-000, Brazil.
Publications dans "Mastadenovirus" :
4 publications dans cette catégorie
Affiliations :
Laboratório de Microbiologia Molecular, Universidade Feevale, ERS 239 no. 2755, Novo Hamburgo, RS, 93352-000, Brazil.
Publications dans "Mastadenovirus" :
3 publications dans cette catégorie
Affiliations :
Laboratório de Microbiologia Molecular, Universidade Feevale, ERS 239 no. 2755, Novo Hamburgo, RS, 93352-000, Brazil. 0178103@feevale.br.
Publications dans "Mastadenovirus" :
3 publications dans cette catégorie
Affiliations :
Universidade Feevale, Instituto de Ciências da Saúde, Laboratório de Microbiologia Molecular, Novo Hamburgo, Rio Grande do Sul, Brazil.
Publications dans "Mastadenovirus" :
2 publications dans cette catégorie
Affiliations :
WHO WPRO Regional Reference Measles/Rubella Laboratory and NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Changping District, Beijing, 102206, People's Republic of China.
Publications dans "Mastadenovirus" :
2 publications dans cette catégorie
Affiliations :
WHO WPRO Regional Reference Measles/Rubella Laboratory and NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Changping District, Beijing, 102206, People's Republic of China.
Publications dans "Mastadenovirus" :
2 publications dans cette catégorie
Publications dans "Mastadenovirus" :
2 publications dans cette catégorie
Affiliations :
WHO WPRO Regional Reference Measles/Rubella Laboratory and NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Changping District, Beijing, 102206, People's Republic of China. wenbo_xu1@aliyun.com.
Publications dans "Mastadenovirus" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Comparative and Environmental Virology, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil. lorena.macena@aluno.fiocruz.br.
Publications dans "Mastadenovirus" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Comparative and Environmental Virology, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil.
Publications dans "Mastadenovirus" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Comparative and Environmental Virology, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil.
Publications dans "Mastadenovirus" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Comparative and Environmental Virology, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil.
Publications dans "Mastadenovirus" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Comparative and Environmental Virology, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil.
Publications dans "Mastadenovirus" :
2 publications dans cette catégorie
Affiliations :
Laboratório Central da Secretaria de Saúde do Estado do Rio Grande do Sul, LACEN/SES-RS, Av. Ipiranga, 5400, Porto Alegre, RS, 90610-000, Brazil.
Publications dans "Mastadenovirus" :
2 publications dans cette catégorie
Affiliations :
Laboratório Central da Secretaria de Saúde do Estado do Rio Grande do Sul, LACEN/SES-RS, Av. Ipiranga, 5400, Porto Alegre, RS, 90610-000, Brazil.
Publications dans "Mastadenovirus" :
2 publications dans cette catégorie
Affiliations :
Laboratório Central da Secretaria de Saúde do Estado do Rio Grande do Sul, LACEN/SES-RS, Av. Ipiranga, 5400, Porto Alegre, RS, 90610-000, Brazil.
Publications dans "Mastadenovirus" :
2 publications dans cette catégorie
Affiliations :
Centro Estadual de Vigilância em Saúde da Secretaria de Saúde do Estado do Rio Grande do Sul-CEVS/SES-RS, Av. Ipiranga, 5400, Porto Alegre, RS, 90610-000, Brazil.
Publications dans "Mastadenovirus" :
2 publications dans cette catégorie
Affiliations :
Universidade Feevale, Instituto de Ciências da Saúde, Laboratório de Microbiologia Molecular, Novo Hamburgo, Rio Grande do Sul, Brazil.
Publications dans "Mastadenovirus" :
2 publications dans cette catégorie
Affiliations :
Universidade Feevale, Instituto de Ciências da Saúde, Laboratório de Microbiologia Molecular, Novo Hamburgo, Rio Grande do Sul, Brazil.
Publications dans "Mastadenovirus" :
In this work, the production of inhalable polymeric microparticles with modulable porosity is described. The starting polymeric material was the PHEA-g-RhB-g-PLA graft copolymer, which was suitably pr...
This contribution is focused on the preparation of a liposomal drug delivery system of erlotinib resisting the nebulization process that could be used for local treatment of non-small-cell lung cancer...
Regulatory science for generic dry powder inhalers (DPIs) in the United States (U.S.) has evolved over the last decade. In 2013, the U.S. Food and Drug Administration (FDA) published the draft product...
Regulatory science for generic dry powder inhalation products worldwide has evolved over the last decade. The revised draft guidance Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI) Products - ...
The device or the formulation? Which one governs drug dispersibility from the inhaler? To address this question, three budesonide-containing reservoir DPIs: Novopulmon Novolizer®, Giona Easyhaler® and...
To review the evidence for the use of open-inhaler (inhaled corticosteroid [ICS] plus long-acting β...
Original research articles were identified from PubMed using the search term "triple therapy asthma." Information was also retrieved from the ClinicalTrials.gov website....
Articles detailing the use of add-on LAMA to ICS plus LABA (open-inhaler triple therapy), and closed triple therapy compared with ICS plus LABA dual therapy, addressing patient symptoms, exacerbations...
Open-inhaler triple therapy was associated with a significantly reduced incidence of hospitalizations and emergency department visits and a decrease in ICS dose, oral corticosteroids use, and antibiot...
Add-on LAMA to ICS plus LABA (open- or single-inhaler triple therapy) improves the response in patients who remain symptomatic and provides a reasonable alternative to ICS dose escalation in treatment...
Checklists are usually employed to assess the inhalation techniques in patients, but partial techniques are difficult to evaluate visually. This study aimed to assess the checklist validity and an agr...
This study used a checklist and an AIM to evaluate the participants' inhalation techniques with a pressurized metered-dose inhaler (MDI) and two dry powder inhalers (DPIs). The kappa (κ) coefficient, ...
The checklist and AIM exhibited poor agreement in the MDI for actuation and inhalation time, and a moderate agreement for inspiratory flow. The fair agreement was observed in DPIs for inspiratory flow...
The checklist tended to overestimate the accuracy of critical techniques including the actuation and inhalation time in MDIs and the inspiratory flow in DPIs. Thus, the AIM device can be used as an ob...
Pulmonary hypertension (PH) and right ventricular (RV) dysfunction are major complications in cardiac surgery. Intraoperative management of patients at high risk of RV failure should aim to reduce RV ...
This is a retrospective cohort study of consecutive patients with PH or RV dysfunction undergoing on-pump cardiac surgery at the Montreal Heart Institute from July 2013 to December 2018 (n = 128). iE&...
In this cohort, 77.3% of patients were responders to iE&iM treatment. Baseline systolic pulmonary artery pressure (SPAP) (odds ratio [OR], 1.63; 95% confidence interval [CI], 1.24-2.16 per 5 mm Hg; P ...
A positive pulmonary vasodilator response to treatment with a combination of iE&iM before initiation of CPB was observed in 77% of patients. Higher baseline SPAP was an independent predictor of pulmon...
Treatment guidelines recommend triple therapy for patients with asthma who remain uncontrolled on inhaled corticosteroid/long-acting β...
To compare adherence and persistence among adult patients with asthma receiving single-inhaler FF/UMEC/VI versus multiple-inhaler triple therapy (MITT) in the United States....
This retrospective cohort study used IQVIA PharMetrics Plus data to evaluate patients with asthma who initiated once-daily FF/UMEC/VI 100/62.5/25 mcg or MITT between September 18, 2017, and September ...
The study included 1396 FF/UMEC/VI and 5115 MITT initiators. Three months after initiation, FF/UMEC/VI users had significantly higher mean PDC versus MITT users (0.68 vs 0.59; P < .001) and 31% more l...
Patients with asthma initiating triple therapy with FF/UMEC/VI had significantly better adherence and persistence compared with MITT initiators....
Inhalation of herbs and other compounds has a long history but habits for medical treatment are intertwined with rituals to obtain hallucinatory effects and pleasurable sensations. Several examples of...
Examples of ancient inhalation and the development of early dry powder inhalers up to and including the first half of the twentieth century. Databases used for literature about historic events, ancien...
Inhalation does not necessarily require active creation of inhalable aerosols, smokes or fumes. Inhaling 'healthy air' with volatile and gaseous components, or fine aerosols in pine forests, on volcan...